Brief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
01/07/2024 11:19
July 1 (Reuters) -
* EFFECTIVE JUNE 27, EBRAHIM "EBOO" VERSI RESIGNED AS
CHAIRMAN
* EFFECTIVE JUNE 27, VERSI WAS SEPARATED FROM HIS ROLE AS
CHIEF
EXECUTIVE OFFICER
Source text for Eikon: ID:n0001999371-24-008002
Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update